Explore All Access
Check if your research matches the topics covered in China Oncology?
- Degree of match
- Common matching concepts
- Additional journal recommendations
China Oncology : Impact Factor & More
pISSN: 1007-3639
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
China Oncology Journal Specifications
Indexed in the following public directories
Scopus 
DOAJ
| Overview | |
| Publisher | Editorial Office of China Oncology |
| Language | English,Chinese |
| Article Processing Charges | CNY 5000 |
| Publication Time | 20 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English,Chinese |
| Society/Institute/Sponsor | Fudan University Shanghai Cancer Center |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in China Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in China Oncology
Trastuzumab deruxtecan的临床研究进展及展望——HER2耐药患者的新希望
- 3 Sep 2021
- China Oncology
Clinical significance of CCL2 expression in osteosarcoma tissue
- 9 Jul 2021
- China Oncology
Application and research progress of selective internal radiation therapy with 90 Y microspheres in hepatocellular carcinoma
- 31 May 2021
- China Oncology
Mechanism of colorectal cancer cell exosome-derived circ_0044366 in regulating release of MMP2 in fibroblasts and promoting metastasis of colorectal cancer
- 31 May 2021
- China Oncology
Exosomal transfer of macrophage-derived miR-223 confers oxaliplatin resistance in gastric cancer
- 31 May 2021
- China Oncology
A study on the tumorigenic effect of HIF-1α on human colorectal cancer cells in nude mice
- 31 May 2021
- China Oncology
Trastuzumab deruxtecan的临床研究进展及展望——HER2耐药患者的新希望
- 3 Sep 2021
- China Oncology
Clinical significance of CCL2 expression in osteosarcoma tissue
- 9 Jul 2021
- China Oncology
Application and research progress of selective internal radiation therapy with 90 Y microspheres in hepatocellular carcinoma
- 31 May 2021
- China Oncology
Mechanism of colorectal cancer cell exosome-derived circ_0044366 in regulating release of MMP2 in fibroblasts and promoting metastasis of colorectal cancer
- 31 May 2021
- China Oncology
Exosomal transfer of macrophage-derived miR-223 confers oxaliplatin resistance in gastric cancer
- 31 May 2021
- China Oncology
A study on the tumorigenic effect of HIF-1α on human colorectal cancer cells in nude mice
- 31 May 2021
- China Oncology
Compare Similar Journals with China Oncology
Select Journals to Compare with China Oncology
Total journals - 9
You can select up to 3 Journals at a time
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Clinical Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Annals of Oncology
Publisher: ELSEVIER
Cancer Letters
Publisher: ELSEVIER IRELAND LTD
Oral Oncology
Publisher: ELSEVIER
Cancers
Publisher: MDPI
Oncology Reports
Publisher: SPANDIDOS PUBL LTD
Oncotarget
Publisher: Impact Journals
0 Journals Selected to compare with
China Oncology
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on China Oncology
How many articles did China Oncology publish last year? 
In 2023, China Oncology publsihed undefined articles.
Who is the publisher of China Oncology?
Editorial Office of China Oncology is the publisher of China Oncology.
